1Fraitag B, Hostein J, Pascaud X, Junien JL. Trimebutine.Pharmacology, recent concepts about its mechanism of action, therapeutic results Gastroenterol Clin Biol, 1992,16: 413～420.
2Frexinos J, Fioramonti J, Bueno L. Effect of trimebutine on colonic myoelectrical activity in IBS patients. Eur J Clin Pharmacol, 1985, 28: 181～185.
3Aktas A, Caner B, Ozturk F, Bayhan H, Narin Y, Mentes T. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Med,1999, 13: 231～234.
4Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut, 1999, 45Suppl 2: Ⅱ 43～Ⅱ 47.
5Kountouras J, Chatzopoulos D, Zavos C, Boura P,Venizelos J, Kalis A. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology, 2002, 49: 193～197.
6Drossman DA, Camilleri M, Mayer EA, Whitehead WE.AGA technical review on irritable bowel syndrome. Gastroenterology, 2002, 123: 2108～2131.
7Delvaux M, Wingate D. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J Int Med Res, 1997, 25: 225～246.
